1-20 of 76
Jonathan E. Brammer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Activating STAT3 Mutations Drive CD38 Expression in T-Large Granular Lymphocytic Leukemia

Giulia Calabretto, Elena Buson, Zachary Hutchins, Colleen Isabelle, Sydnee Scozzafava, Valentina Trimarco, Barbara Mariotti, Rachel Burzinski, Amy Boles, Elisa Rampazzo, Antonella Teramo, Sabrina Manni, Monica Facco, Gregorio Barilà, Flavia Bazzoni, Gianpietro Semenzato, Livio Trentin, Jonathan E. Brammer, Renato Zambello, Anjali Mishra
Journal: Blood
Blood (2024) 144 (Supplement 1): 4132.
https://doi.org/10.1182/blood-2024-210469
Published: 2024
Journal Articles

Final Results of a Phase 2, Single Arm Trial Evaluating Letermovir for Cytomegalovirus Prophylaxis in Patients with Hematological Malignancies Treated with Alemtuzumab

John C. Reneau, Ying Huang, Walter Hanel, Catherine Chung, Jonathan E. Brammer, Basem William
Journal: Blood
Blood (2024) 144 (Supplement 1): 6390.
https://doi.org/10.1182/blood-2024-201307
Published: 2024
Journal Articles

Patterns of Use and Outcomes of Novel Agents in Patients with Relapsed or Refractory Large B-Cell Lymphoma: A Single-Center Retrospective Analysis

Sonia Godbole, Rina Li Welkie, Audrey M. Sigmund, Timothy Voorhees, Walter Hanel, David A. Bond, John C. Reneau, Lapo Alinari, Jonathan E. Brammer, Beth Christian, Robert Baiocchi, Kami J. Maddocks, Yazeed Sawalha
Journal: Blood
Blood (2024) 144 (Supplement 1): 4460.
https://doi.org/10.1182/blood-2024-207738
Published: 2024
Journal Articles

Final Results of a Phase II Study of Brentuximab Vedotin and Lenalidomide in Relapsed and Refractory T-Cell Lymphomas

John C. Reneau, Ying Huang, Walter Hanel, Jonathan E. Brammer, Catherine Chung, Basem William
Journal: Blood
Blood (2024) 144 (Supplement 1): 4438.
https://doi.org/10.1182/blood-2024-201294
Published: 2024
Journal Articles

Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of KT-333, a Targeted Protein Degrader of STAT3, in Patients with Relapsed or Refractory Lymphomas, Leukemia, and Solid Tumors

Tatyana Feldman, Enrica Marchi, Stephen D. Smith, Adam J. Olszewski, Auris O Huen, Zachary D. Epstein-Peterson, Don A. Stevens, Alexander N. Starodub, Eric J. Feldman, Cristina P Rodriguez, John C. Reneau, Jonathan E. Brammer, Ahmad H. Mattour, Lauren C. Pinter-Brown, Rachelle Perea, Patrick Henrick, Joyoti Dey, Alyssa Fasciano, Rahul Karnik, Sagar Agarwal, Ashwin Gollerkeri, Jared Gollob, Aditi Shastri, Stefan K. Barta
Journal: Blood
Blood (2024) 144 (Supplement 1): 4433.
https://doi.org/10.1182/blood-2024-210301
Published: 2024
Journal Articles

Association between Post-CART Terminal Complement Complex Levels and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)

Evandro Bezerra, George Durisek, III, Qiuhong Zhao, Nathan Denlinger, Timothy Voorhees, Gabriela Sanchez-Petitto, Francesca Cottini, Audrey M. Sigmund, Yazeed Sawalha, Polina Shindiapina, Sarah A. Wall, David A. Bond, Hannah Choe, Jonathan E. Brammer, Beth Christian, Sam Penza, Samantha M. Jaglowski, Kami J. Maddocks, Spero Cataland, Marcos de Lima, Sumithira Vasu
Journal: Blood
Blood (2024) 144 (Supplement 1): 3446.
https://doi.org/10.1182/blood-2024-198872
Published: 2024
Journal Articles

Comparison of Two Myeloablative Total-Body Irradiation (MAC-TBI) Regimens: 1200 Cgy Vs 800 Cgy of TBI for Allogeneic Stem Cell Transplantation in Adults with Hematological Malignancies

Gabriela Sanchez-Petitto, Ying Huang, Evandro Bezerra, Jonathan E. Brammer, Hannah Choe, Nathan Denlinger, Polina Shindiapina, Sam Penza, Sarah A Wall, Gregory K Behbehani, James S. Blachly, Bradley Wayne Blaser, Uma Borate, Ann-Kathrin Eisfeld, Nicole R. Grieselhuber, Kristin L Koenig, Karilyn T. Larkin, Meixiao Long, Alice Mims, Andrew Srisuwananukorn, Ayman Saad, Sumithira Vasu, Marcos de Lima
Journal: Blood
Blood (2024) 144 (Supplement 1): 7303.
https://doi.org/10.1182/blood-2024-194146
Published: 2024
Journal Articles

GATA2 -Mutated AML: Clinical Outcomes and Spectrum of Infections in Patients Undergoing or Not Allogeneic Stem Cell Transplantation

Gabriela Sanchez-Petitto, Zeinab El Boghdadly, Deedra Nicolet, Julia Cooper, Ann-Kathrin Eisfeld, Victoria Klein, Michael C Walker, Krzysztof Mrózek, Evandro Bezerra, Jonathan E. Brammer, Nathan Denlinger, Polina Shindiapina, Sam Penza, Sarah A. Wall, Gregory K Behbehani, James S. Blachly, Bradley Wayne Blaser, Uma Borate, Nicole R. Grieselhuber, Kristin L Koenig, Karilyn T. Larkin, Meixiao Long, Alice Mims, Andrew Srisuwananukorn, Sumithira Vasu, Marcos de Lima
Journal: Blood
Blood (2024) 144 (Supplement 1): 7309.
https://doi.org/10.1182/blood-2024-202650
Published: 2024
Journal Articles

Survival and Therapeutic Outcomes in T-Cell Prolymphocytic Leukemia (T-PLL): A Collaborative Multi-Center Study Cohort

Zachary Braunstein, Eric McLaughlin, Prasanth Lingamaneni, Stefan K. Barta, Miao Cao, Tiffany Chang, Nivetha Ganesan, Binh Luu, Neha Mehta-Shah, Tanaya Shree, Marcus P. Watkins, Jasmine Zain, Pamela B. Allen, Darina Paulino, Brittany Adams, Jie Wang, Amber Feng, Enrica Marchi, Nathan Roberts, Ryan A. Wilcox, Marc Gabriel Gutierrez, Zachary AK Frosch, Tammarah Sklarz, Tarsheen Sethi, Francine M. Foss, Anne W Beaven, Bradley M. Haverkos, Rachel Treitman, Patrick Stevens, Anjali Mishra, Robert Stuver, Paul J Hampel, Jonathan E. Brammer
Journal: Blood
Blood (2024) 144 (Supplement 1): 982.
https://doi.org/10.1182/blood-2024-194242
Published: 2024
Journal Articles

Results from the First Phase 1 Clinical Study of DR-01, a Non-Fucosylated Anti-CD94 Targeting Antibody in Patients with Relapsed/Refractory Cytotoxic Lymphomas: Dose Escalation and Optimization

Jasmine Zain, Swaminathan P Iyer, Enrica Marchi, Mitul Gandhi, Youn H. Kim, Michael S. Khodadoust, Jonathan E. Brammer, Christina Poh, Pierluigi Porcu, Kimberley Dilley, Matthias Will, Andrea Kantor, Cathrine Leonowens, Nenad Tomasevic, H. Miles Prince, Steven Horwitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 980.
https://doi.org/10.1182/blood-2024-206053
Published: 2024
Journal Articles

Steroid Prophylaxis in Patients Receiving CAR T-Cell Therapy for Relapsed and Refractory Non-Hodgkin Lymphoma

Jacob Butman, Alma Habib, Rina Li Welkie, Yazeed Sawalha, Audrey M. Sigmund, Beth Christian, Kami J. Maddocks, Walter Hanel, David A. Bond, Lapo Alinari, Robert Baiocchi, Hannah Choe, John C. Reneau, Gabriela Sanchez-Petitto, Jonathan E. Brammer, Evandro Bezerra, Timothy Voorhees, Sumithira Vasu, Sarah A. Wall, Marcos de Lima, Nathan Denlinger
Journal: Blood
Blood (2024) 144 (Supplement 1): 4507.
https://doi.org/10.1182/blood-2024-206559
Published: 2024
Journal Articles

Duvelisib in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma: Final Results from the Phase 2 PRIMO Trial

Neha Mehta-Shah, Pier Luigi Zinzani, Eric D. Jacobsen, Jasmine Zain, Monica Mead, Carla Casulo, Giuseppe Gritti, Lauren C. Pinter-Brown, Koji Izutsu, Ohad S Bentur, David Sidransky, Jonathan E. Brammer, Barbara Pro, Christopher P. Fox, Steven Horwitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 3061.
https://doi.org/10.1182/blood-2024-203577
Published: 2024
Journal Articles

Nivolumab in Combination with Dose Adjusted (DA) R-EPOCH for First-Line Treatment of Large B-Cell Lymphoma: Results from a Phase II Trial

David A. Bond, Ying Huang, John C. Reneau, Yazeed Sawalha, Jonathan E. Brammer, Timothy Voorhees, Narendranath Epperla, Audrey M. Sigmund, Lapo Alinari, Walter Hanel, Anna Gilmore, Misty Fleming, Kathleen Stamper, Robert Baiocchi, Beth Christian, Kami J. Maddocks
Journal: Blood
Blood (2024) 144 (Supplement 1): 1719.
https://doi.org/10.1182/blood-2024-194545
Published: 2024
Journal Articles

Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy Is Associated with Inferior Survival for Patients with Relapsed or Refractory Large B-Cell Lymphoma

John Sharp, Qiuhong Zhao, Timothy Voorhees, David A. Bond, Yazeed Sawalha, John C. Reneau, Audrey M. Sigmund, Walter Hanel, Lalit Sehgal, Lapo Alinari, Robert Baiocchi, Jonathan E. Brammer, Kami J. Maddocks, Beth Christian, Evandro Bezerra, Nathan Denlinger, Sumithira Vasu, Marcos de Lima, Jason Prosek, Narendranath Epperla
Journal: Blood
Blood (2024) 144 (Supplement 1): 3747.
https://doi.org/10.1182/blood-2024-203798
Published: 2024
Journal Articles

Real-World Evaluation of T-Prolymphocytic Leukemia Outcomes Using the 2019 T-PLL International Study Group Criteria

Zachary Braunstein, Eric McLaughlin, Anjali Mishra, Pierluigi Porcu, Jonathan E. Brammer
Journal: Blood
Blood (2023) 142 (Supplement 1): 6213.
https://doi.org/10.1182/blood-2023-184602
Published: 2023
Journal Articles

A Multicenter Real-World Analysis (RWA) of Primary Cutaneous Anaplastic Large Cell Lymphoma (PCALCL) Treated in the Modern Era

Deepa Jagadeesh, Stefan K. Barta, Jonathan E. Brammer, Wei Wei, Julie E Chang, Rahul Mishra, Tavakkoli Montreh, Alma Habib, Marcus P Watkins, Yash Deshmukh, Sharina C Macapagal, Madiha Iqbal, N. Nora Bennani, Frederick Lansigan, Neha Mehta-Shah
Journal: Blood
Blood (2023) 142 (Supplement 1): 6177.
https://doi.org/10.1182/blood-2023-191176
Published: 2023
Journal Articles

Zanubrutinib in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): Interim Results from a Phase 1b Clinical Trial

Yazeed Sawalha, Rina Li Welkie, Anna Krivenko, Brian Hess, Audrey M. Sigmund, Timothy Voorhees, Walter Hanel, David A. Bond, John C Reneau, Narendranath Epperla, Lapo Alinari, Jonathan E. Brammer, Beth Christian, Robert Baiocchi, Kami J. Maddocks
Journal: Blood
Blood (2023) 142 (Supplement 1): 6226.
https://doi.org/10.1182/blood-2023-182941
Published: 2023
Journal Articles

Post-Allograft Romidepsin Maintenance Mitigates Relapse Risk and Stimulates the Graft-Versus-Malignancy Effect through Enhanced NK-Cell Cytotoxicity in Patients with T-Cell Malignancies: Final Results of a Phase I/II Trial

Chitra Hosing, Zachary Braunstein, Eric McLaughlin, Benigno C. Valdez, Borje S. Andersson, Uday R. Popat, Sumithira Vasu, Evandro Bezzera, Gabriela Sanchez-Petitto, Sarah A Wall, Samantha M. Jaglowski, Sam Penza, Hannah Choe, Lai Wei, Robin Nakkula, Alex Cash, Richard E. Champlin, Marcos de Lima, Steven M. Devine, Dean Anthony Lee, Jonathan E. Brammer
Journal: Blood
Blood (2023) 142 (Supplement 1): 184.
https://doi.org/10.1182/blood-2023-190213
Published: 2023
Journal Articles

Differences in Observed Toxicities for Adolescent and Young Adult Patients with Aggressive Mature B-Cell Lymphomas Treated at Adult Versus Pediatric Cancer Center - a Comparative Cohort Study

Allison M Lehanka, Ann Kebede, Neda Amirmokhtari, Joseph R Stanek, Narendranath Epperla, Beth Christian, Robert Baiocchi, Timothy Voorhees, Kami J. Maddocks, Yazeed Sawalha, John C Reneau, Jonathan E. Brammer, Audrey M. Sigmund, Faye Willen, Nick Yeager, Anthony N. Audino, David A. Bond
Journal: Blood
Blood (2023) 142 (Supplement 1): 3116.
https://doi.org/10.1182/blood-2023-187194
Published: 2023
Journal Articles

Gemcitabine and Liposomal Doxorubicin (GemDox) for the Treatment of Relapsed and Refractory T-Cell Lymphomas

Zachary Braunstein, Allyson Waller, Emily Dotson, Eric McLaughlin, Walter Hanel, John C Reneau, Daniel Addison, Pierluigi Porcu, Jonathan E. Brammer
Journal: Blood
Blood (2023) 142 (Supplement 1): 4453.
https://doi.org/10.1182/blood-2023-184583
Published: 2023